Pfizer clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
76 trials changed in the last 30 days: 2 stopped, 17 with notable changes, 57 with minor changes only.
- Notable: Symbiotic-Lung · 04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy and With Tarlatamab, Alone or With Chemotherapy, · Extensive-Stage Small Cell Lung Cancer Primary endpoint(s) modified
- Notable: Continuation Study of Tilrekimig · Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time Recruitment opened
- Minor: Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer · Different Histologies Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Minor: How a New Pneumococcal Vaccine Works in Infants Trial sites expanded: 130 → 134 locations
- Minor: PF-08165784 · PIK3CA-Mutated Advanced or Metastatic Solid Tumors Trial sites expanded: 0 → 5 locations
- Notable: (Called Marstacimab) · Hemophilia A or B Recruitment opened
- Minor: XRPMS · Korean Post-marketing Surveillance for Xeljanz XR Trial completed
- Minor: ENDEAVOUR-UC · Etrasimod · Moderate to Severe Ulcerative Colitis Enrollment closed, study ongoing
- Minor: Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec · Hemophilia A or B Respectively Trial sites expanded: 39 → 44 locations
- Minor: MOUNTAINEER-03 · Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer Enrollment closed, study ongoing
- Minor: PF-08098488 · Advanced Solid Tumors Start date changed from estimate of Oct 29, 2026 to Nov 5, 2026
- Notable: Somatrogon · Pediatric Growth Hormone Deficiency (p GHD) in India Primary completion pushed from Sep 21, 2026 to Sep 5, 2028
- Minor: Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults Enrollment closed, study ongoing
- Minor: Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema Enrollment closed, study ongoing
- Minor: ATGAM General Investigation Primary and study completion pushed from Jan 22, 2027 to Mar 26, 2027
- Minor: This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works · Non-small Cell Lung Cancer With High Levels of PD-L1 Trial sites expanded: 389 → 392 locations
- Notable: Atirmociclib in Combination With Giredestrant · ER-positive, HER2-negative Early-stage Breast Cancer Primary endpoint(s) modified
- Notable: CDK4i · PF-07220060 · Advance Solid Tumors Phase changed: Phase 1/2 → Phase 2
- Minor: 16-Week Study to Learn About the Study Medicine Called Ritlecitinib · Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS Trial sites reduced: 60 → 57 locations
- Minor: Vepdegestrant (ARV-471, PF-07850327) · ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC) Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Active, Not Recruiting
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-12 | NCT07932925 The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide… | Phase 3 | Not Yet Recruiting |
| 2026-11-12 | NCT07933835 A Study to Learn How Different Amounts of the Study Medicine Called PF-08166744 Are… | Phase 1 | Not Yet Recruiting |
| 2026-11-12 | NCT07933848 A Study to Learn About the Study Medicine Called Prifetrastat in People With Renal… | Phase 1 | Not Yet Recruiting |
| 2026-11-09 | NCT07923981 A Study to Assess the Safety of Marstacimab and How Well it Works in People With Mild to… | Phase 3 | Recruiting |
| 2026-11-09 | NCT07927023 A Study to Learn About a Medicine (Called Elranatamab) in People With Relapsed Refractory… | Not Yet Recruiting | |
| 2026-11-05 | NCT07919678 A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and… | Phase 3 | Recruiting |
| 2026-11-04 | NCT07915609 A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis… | Phase 3 | Recruiting |
| 2026-11-02 | NCT07909122 Real-World Treatment Patterns and Effectiveness of Anti-EGFR- and Anti-VEGF-based… | Not Yet Recruiting | |
| 2026-10-30 | NCT07906262 Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual… | Active, Not Recruiting | |
| 2026-10-29 | NCT07903415 A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced… | Phase 1 | Recruiting |
Active trials by phase
| Phase 1 | 46 | |
| Phase 1/2 | 10 | |
| Phase 2 | 29 | |
| Phase 2/3 | 5 | |
| Phase 3 | 94 | |
| Phase 4 | 10 |
Not charted: 67 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 54
Lung Cancer (33) · Breast Cancer (29) · Non-Small Cell Lung Cancer (NSCLC) (29) · Obesity (20) · Colorectal Cancer (16) · Atopic Dermatitis (14) · Migraine (14) · Multiple Myeloma (12) · Bladder Cancer (10) · Prostate Cancer (10)
Get alerts when Pfizer's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.